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MicroRNAs (miRNAs) are a group of endogenous noncoding RNAs that play important roles in many biological processes. This
study aimed to check if miRNAs were involved in the response to acupuncture in rats. Microarray analysis was performed to
compare the miRNA expression profiles of medulla in spontaneously hypertensive rats (SHRs) treated with or without acupuncture.
Our microarray analysis identified 222 differentially expressed miRNAs in the medulla of SHRs treated with acupuncture at taichong
acupoint. Among these miRNAs, 23 miRNAs with a significant difference were found in acupuncture-treated SHRs compared
to untreated rats. These 23 miRNAs could regulate 2963 target genes which were enriched in at least 14 pathways based on our
bioinformatic analysis. miRNA-339, miR-223, and miR-145 were downregulated in the medulla of SHRs compared to normotensive
rats. Notably, these miRNAs were upregulated to basal levels in the medulla of SHRs treated with acupuncture at taichong in
comparison with SHRs receiving acupuncture at nonacupoint group or SHRs without any treatment. Our findings have revealed
significant changes of a panel of selective miRNAs in hypertensive rats treated at taichong acupoint. These data provide insights
into how acupuncture elicits beneficial effects on hypertension.

1. Introduction
Hypertension, a major risk factor for cardiovascular disease,
affects approximately one billion individuals worldwide [1],
including 78 million (33%) American adults ≥20 years of
age (i.e., it affects one in three adults in the United States)
[2]. Although a number of treatment strategies have been
developed for this disease, only 75% of hypertensive patients
received pharmacologic treatment, and only 53% of those
with documented hypertension have their condition controlled to target levels [2]. The major barriers to successful
pharmacotherapeutic control of hypertension are poor drug
response, adverse side effects, and low patient compliance [3].

Acupuncture originated in ancient China at least 2,500
years ago. Although there is some controversy in mainstream
Western medicine, it has become one of the most widely
practiced forms of alternative medicine in the world [4].
For example, estimated 3 million American adults receive
acupuncture treatment each year [5]. The US Internal Revenue Service approved acupuncture as deductible medical
expense in 1973. The National Institute of Health has sponsored a Consensus Development Conference on Acupuncture in 1997 [6]. WHO has approved acupuncture as an
alternative therapy for the treatment of at least 64 types of
diseases. On November 16, 2010, acupuncture has been listed
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by the United Nations Educational, Scientific, and Cultural
Organization as “Intangible Cultural Heritage.”
Since the 1970s, a number of animal and clinical studies have demonstrated the effectiveness of acupuncture
at specific acupoints to lower blood pressure in essential
hypertension [7–10]. Unfortunately, the underlying mechanisms through which acupuncture lowers blood pressure
remain unclear. Studies have suggested the involvement of
nitric oxide (NO) [11], neurotransmitters [12], aldosterone,
endothelin, and angiotensin II [13, 14], and acetylcholine, opioids, 𝛾-aminobutyric acid, serotonin, and endocannabinoids
in the brain all appear to contribute to the acupuncture’s
antihypertensive effect [15, 16].
The small noncoding microRNAs (miRNAs) have critical
functions in the regulation of various critical biological
processes such as cell metabolism, proliferation, death, and
development [17, 18]. To date, there are more than 2,000 miRNAs reported in humans. A number of studies have found
that miRNAs respond to various therapeutic interventions
such as pharmacotherapy, physical therapy, and radiotherapy.
However, there is no information on the effect of acupuncture
therapy on miRNA profiles in animals and humans. The
objective of the present study was to determine whether
miRNAs were involved in the response to acupuncture
therapy in rats. This study is the first to examine the miRNA
response in the medulla of rats to acupuncture at the taichong
(LR3) point compared to stimulation at a nonacupoint in
spontaneously hypertensive rats (SHRs).

2. Materials and Methods
2.1. Ethics Statement. All animal experiments were performed at the Laboratory Animal Center of Guangzhou
University of Chinese Medicine, Guangzhou, China. The procedure was approved by the Ethics Committee of Guangzhou
University of Chinese Medicine, Guangzhou, China [permit
number: SYXK (Yue) 2008-0085].
2.2. Chemicals and Reagents. The 6th generation of miRCURYTM LNA Array (v.16.0) was obtained from KangChen
Bio-tech (Shanghai, China), which contains more than 1891
capture probes, covering all human, mouse, and rat microRNAs annotated in miRBase 16.0, as well as all viral microRNAs related to these species. In addition, this array contains
capture probes for 66 new miRPlus human microRNAs. All
chemicals and reagents used were of analytical grade.
2.3. Animals. The experiments were performed with SHRs
and Sprague-Dawley (SD) rats provided by Beijing Vital
River Laboratory Animals Co., Ltd (Beijing, China). The
rats were housed in cages maintained in a temperature- and
humidity-controlled room at the Laboratory Animal Center
of Guangzhou University of Chinese Medicine, Guangzhou,
China. The animals were given a standard diet. The SHRs
with confirmed blood pressure ≥ 140 mmHg were included
and randomly divided into three groups: (1) acupuncture at
taichong group (𝑛 = 6) treated with acupuncture at LR3
point, (2) acupuncture at nonacupoint group (𝑛 = 6) treated
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with acupuncture at nonacupoints, and (3) model group (𝑛 =
6) untreated with acupuncture throughout the duration of the
experiment. In the literature, SD rats have been used as the
normotensive controls in comparison to SHRs [19, 20] and
thus they were used as normal control group (𝑛 = 6) in this
study.
2.4. Acupuncture Procedure. A number of clinical and animal
studies have reported the efficacy of acupuncture at taichong
point in reducing hypertension [21–23]. The acupuncture
treatment procedure was the same as described previously by
us [22]. Briefly, in acupuncture taichong group, acupuncture
was performed at bilateral taichong points (LR3) located
between the 1st and the 2nd metatarsal of dorsal foot, while,
in acupuncture nonacupoint group, acupuncture was done
at bilateral nonacupoint located at the fossa between the 3rd
and 4th metatarsal of dorsal foot (Figure 1). As previously
described [22, 24], the rats were lightly immobilized and the
acupuncture needles were inserted to a depth of 3 mm at the
appropriate location bilaterally, twisted at a rate of 80 spins
per min, and removed afterward. This treatment was given
daily (treatment lasting 5 min/day) for 7 consecutive days.
After the last acupuncture treatment, rats were anesthetized
and their medullas were quickly dissected. The medullas were
preserved in liquid nitrogen until analysis.
2.5. Microarray Analysis. Total RNA was isolated using
TRIzol (Invitrogen, Grand Island, NY, USA) and miRNeasy
minikit (QIAGEN) according to manufacturer’s instruction. After RNA isolation from the samples, the miRCURY
Hy3/Hy5 Power labeling kit (Exiqon, Vedbaek, Denmark)
was used according to the manufacturer’s guideline for
miRNA labelling. One microgram of each sample was 3 end-labeled with Hy3 fluorescent label, using T4 RNA ligase.
After stopping the labeling procedure, the Hy3-labeled samples were hybridized on the miRCURY LNA Array (v.16.0)
(Exiqon) according to the manufacturer’s manual. The slides
were scanned using the Axon GenePix 4000B microarray
scanner (Axon Instruments, Foster City, CA, USA). Scanned
images were then imported into GenePix Pro 6.0 software
(Axon) for grid alignment and data extraction. Replicated
miRNAs were averaged and miRNAs in which intensities
>50 in all samples were chosen for calculating the normalization factor. The data were normalized using the Median
normalization method and after normalization differentially
expressed miRNAs were identified through Volcano Plot
filtering. In addition, hierarchical clustering was performed
using MEV software (v4.6, TIGR).
2.6. Bioinformatics Studies. Computational target prediction
of miRNAs was conducted by miRDB online searching
program (http://mirdb.org/miRDB/). The enriched KEGG
pathway for these targets was analyzed in DAVID Bioinformatics Resources 6.7 (http://david.abcc.ncifcrf.gov/).
2.7. Quantitative Real-Time PCR (qRT-PCR). The rat medulla
was homogenized in 400 𝜇L of TRIzol reagent (Invitrogen,
Grand Island, NY, USA). To avoid contamination with
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Table 1: miRNAs upregulated by acupuncture in the medulla of
SHRs.

Medulla
SHR

Taichong

Non
-acupoint

Target
identification

Microarray

qRT-PCR

Bioinformatic
analysis

Mature miRNAs Fold-change
(rno-miR-)
(mean ± SEM)

𝑃 value

miRBase accession
number

339
223
145
451
193
378
423
let-7b∗

0.0214
0.0011
0.0059
0.0097
0.0300
0.0135
0.0277
0.0443

MIMAT0000583
MI0000963
MI0000918
MI0001731
MI0000936
MI0003719
MI0006145
MIMAT0004705

2.13
3.34
3.02
3.32
2.88
2.30
1.97
1.70

Each experiment was performed in triplicate. The fold change is presented
as the mean ± SEM.∗ Indicates antisense mature miRNA.

Figure 1: The acupuncture procedure at taichong point and nonacupoint in SHRs. In taichong group of the SHRs, acupuncture was
performed at bilateral LR3 located between the 1st and the 2nd
metatarsal of dorsal foot, while, in nonacupoint group, acupuncture
was done at bilateral nonacupoint located at fossa between the 3rd
and 4th metatarsal of dorsal foot.

genomic DNA, the RNA samples were treated with RNasefree DNase (Promega, Madison, WI, USA). Reverse transcription was performed using M-MLV reverse transcriptase
(Promega, Madison, WI, USA). Real-time RT-PCRs were
carried out using an ABI PRISM 7500 Sequence Detection
System (Applied Biosystems, Carlsbad, CA, USA) and the
SYBR Green PCR Master Mix kit (Toyobo Co., Ltd., Osaka,
Japan). The 2−ΔΔCt method was used to analyze the RT-PCR
data and the ΔCt of each miRNA was determined relative to
U6 RNA and endogenous control miRNA that is robustly and
invariantly expressed in all cell types. The experiments were
performed in triplicate, and consistent results were obtained.
2.8. Statistical Analysis. Data are presented as the mean
± SD. Multiple comparisons were evaluated by one-way
analysis of variance (ANOVA) followed by Tukey’s multiple
comparison procedure, with 𝑃 < 0.05 considered significant.
All statistical tests were performed using Prism software
version 6.0 (GraphPad Software Inc., Chicago, IL, USA).

Table 2: miRNAs downregulated by acupuncture in the medulla of
SHRs.
Mature miRNAs Fold-change
(rno-miR-)
(mean ± SEM)

𝑃 value

miRBase accession
number

7a
9
128
132
134
182
335
382
383
434
496
135a
136∗
376b-5p
384-3p

0.0254
0.0491
0.0229
0.031
0.0037
0.0093
0.0475
0.0381
0.0324
0.0155
0.011
0.0414
0.0131
0.0052
0.0225

MI0000641
MI0000838
MI0000900
MI0000905
MI0000907
MI0006133
MI0000612
MI0003548
MI0003478
MI0006147
MI0012622
MI0000908
MIMAT0004733
MIMAT0003195
MIMAT0005310

0.52
0.48
0.45
0.42
0.59
0.24
0.6
0.44
0.51
0.44
0.59
0.45
0.58
0.54
0.57

Each experiment was performed in triplicate. The fold change is presented
as the mean ± SEM. ∗ Indicates antisense mature miRNA.

3. Results

miRNAs were significantly downregulated after acupuncture
treatment.

3.1. miRNAs Profiling Response to Acupuncture Therapy in
SHRs. To reveal miRNAs profiling response to acupuncture
therapy in SHRs, microarrays containing 1891 human, rat,
and mouse miRNAs were used to examine the expression of
miRNAs in medullas after acupuncture treatment at taichong
point in SHRs. The analyses were performed using total
RNA collected from three rat medullas. Statistical analysis
of the miRNA expression data identified 222 miRNAs with
significant changes in the expression, with 23 miRNAs having
expression levels greater or equal to a 1.5-fold change in SHRs
with or without acupuncture treatment (Tables 1 and 2).
Among these 23 differentially expressed miRNAs, 8 of
23 miRNAs were significantly upregulated, while 15 of 23

3.2. Confirmation of Microarray Profiling Data by qRT-PCR.
To validate the microarray profiling data, qRT-PCR was used
to confirm the upregulated miRNAs including miRNA-339,
miR-223, miR-145, and miR-451. The data showed that miR339, miR-223, and miR-145 were significantly upregulated in
medullas of SHRs treated with acupuncture at taichong point
in contrast to the model group untreated with acupuncture
(Figure 2). While being compared to the normal control
group (healthy SD rats), miR-339, miR-223, and miR-145 were
significantly downregulated in model group. There was no
significant increase in miR-451 between acupuncture group
and model group or normal group (data not shown).
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Figure 2: Confirmation of miR-339 (a), miR-223 (b), and miR-145 (c) expression changes in the medulla of SHRs treated with acupuncture
at taichong point (model + acu.). The expression level of miR-339, miR-223, and miR-145 in rats was detected using qRT-PCR. The relative
expression of these miRNAs was calculated in relation to levels of U6 RNA using the 2−ΔΔCt method. The result was repeated in triplicate
independent experiments. ∗ 𝑃 < 0.05; ∗∗ 𝑃 < 0.001.

3.3. Acupuncture Treatment at Taichong Acupoint Elicits
Specific miRNA Expression Changes in SHRs. Next, we compared the effect of acupuncture at taichong acupoint or at
nonacupoint on miRNA expression changes in SHR medulla.
The data showed that acupuncture at taichong point significantly increased miRNA-339, miR-223, and miR-145 levels
in medullas of SHRs in contrast to the model group, while
acupuncture at nonacupoint did not significantly alter miR339, miR-223, and miR-145 levels compared to the model
group. Moreover, compared to acupuncture at nonacupoint,
acupuncture at taichong point significantly upregulated the
expression of miRNA-339, miR-223, and miR-145 in medullas
of SHRs (Figure 3). These data showed significantly different
miRNA response to real and sham acupuncture treatments in
rats.

Resources 6.7 (http://david.abcc.ncifcrf.gov/) to analyze
the enriched pathways. From the miRDB online database
(http://mirdb.org/miRDB/), we identified 5223 targets for
all 23 acupuncture-regulated miRNAs when the target
score was set to ≥50. When the target score cut-off was set
at ≥60, 2963 possible targets were predicted. We further
analyzed the enriched KEGG pathways for these 2963 targets
and found 14 pathways, including neurotrophin signaling
pathway, pathways in cancer, MAPK signaling pathway, Wnt
signaling pathway, Ubiquitin mediated proteolysis, cell cycle,
chemokine signaling pathway, oocyte meiosis, tight junction,
T cell receptor signaling pathway, axon guidance, and TGF-𝛽
signaling pathway (Table 3).

3.4. Possible Targets and Their Enriched Pathway of
Acupuncture-Regulated miRNAs by Bioinformatics Analysis.
To explore possible targets and signaling pathways involved
in response to acupuncture, we used miRDB to predict
the targets of the differentially expressed microRNAs
responsive to acupuncture and used DAVID Bioinformatics

In this study, we first found that miRNAs responded
to acupuncture treatment in SHRs. Previous studies have
demonstrated that physical therapy elicited remarkable
miRNA profiling changes in humans [25–28] and mice [29].
Similarly, we have revealed that 222 medullar miRNAs were
involved in acupuncture therapy in SHRs. Of these miRNAs,

4. Discussion
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Figure 3: Acupuncture treatment at taichong acupoint elicits specific miRNA expression changes in SHRs. Acupuncture at taichong point
(Taichong) significantly increased miR-339 (a), miR-223 (b), and miR-145 (c) expression levels in the medullas of SHRs compared to SHRs
with nonacupoint treatment (non-acu.). ∗ 𝑃 < 0.05; ∗∗ 𝑃 < 0.001, ∗∗∗ 𝑃 < 0.001.

Table 3: The enriched KEGG pathways of acupuncture-responsive miRNAs in SHRs.
Category

Term

KEGG
KEGG
KEGG
KEGG
KEGG
KEGG
KEGG
KEGG
KEGG
KEGG
KEGG
KEGG
KEGG
KEGG

Neurotrophin signaling pathway
Pathways in cancer
MAPK signaling pathway
Wnt signaling pathway
Ubiquitin mediated proteolysis
Cell cycle
Chemokine signaling pathway
Calcium signaling pathway
Oocyte meiosis
Tight junction
T cell receptor signaling pathway
Endocytosis
Axon guidance
TGF-beta signaling pathway

PATHWAY
PATHWAY
PATHWAY
PATHWAY
PATHWAY
PATHWAY
PATHWAY
PATHWAY
PATHWAY
PATHWAY
PATHWAY
PATHWAY
PATHWAY
PATHWAY

Thresholds: count cut-off ≥20; EASE <0.1.

Count

%

𝑃 value

Benjamini

21
51
42
38
31
29
29
28
27
22
21
42
21
20

0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1

6.60𝐸 − 02
6.50𝐸 − 03
1.90𝐸 − 02
7.80𝐸 − 07
3.70𝐸 − 05
2.40𝐸 − 04
2.40𝐸 − 02
7.50𝐸 − 02
1.60𝐸 − 04
5.20𝐸 − 02
1.70𝐸 − 02
7.70𝐸 − 05
7.00𝐸 − 02
2.50𝐸 − 03

6.50𝐸 − 01
1.60𝐸 − 01
3.20𝐸 − 01
1.40𝐸 − 04
3.40𝐸 − 03
8.80𝐸 − 03
3.50𝐸 − 01
6.40𝐸 − 01
7.40𝐸 − 03
5.90𝐸 − 01
3.20𝐸 − 01
4.70𝐸 − 03
6.40𝐸 − 01
7.40𝐸 − 02
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although screened by fold change ≥1.5 and 𝑃 value < 0.05,
23 miRNAs were significantly regulated by acupuncture
treatment (Tables 1 and 2). These microarray data were
further validated using qRT-PCR. The findings from this
study suggest that miRNAs are involved in the therapeutic
effects of acupuncture.
Our finding further showed that acupuncture treatment at specific acupoint elicits selective miRNA expression changes in SHRs (Figure 3). Acupoint specificity is
the theoretical basis for meridian and acupuncture theory
and is also the key factor for the application of effective
and individualized acupuncture treatment [30, 31]. However,
there is still some controversy about the existence of acupoint
specificity [32–37]. Our data showed that acupuncture at
taichong acupoint regulated miR-339, miR-223, and miR-145
expression, while acupuncture at nonacupoint failed to affect
these miRNAs’ expression. Other researches have observed
acupoint-specific effect at taichong point in human brain by
functional nuclear magnetic resonance imaging technique
[38].
Our bioinformatics analysis showed that 23 miRNAs
responded to acupuncture and these miRNAs might regulate 2963 targets. These miRNAs have many important
physiological and pathological functions. miRNA-339, miR223, and miR-145 are highly conserved and have multiple
targets predicted for them in both humans and rats [39–
41]. In addition, many studies have demonstrated that these
miRNAs are involved in cell proliferation, apoptosis, and
tumor suppressor. For example, miRNA-339 has been shown
to have a central role in regulating the expression of intercellular cell adhesion molecule-1 [39]. Similarly, miR-223 has
been found to negatively regulate progenitor proliferation
and granulocyte differentiation and activation [42]. miR-145
has been proposed to inhibit human embryonic stem cell
self-renewal, represses expression of pluripotency genes, and
induces lineage-restricted differentiation [41]. miR-145 has
also been proposed as a tumor suppressor that can target the
3 -untranslated region of the insulin receptor substrate-1 gene
and dramatically inhibit the growth of colon cancer cells [43].
Therefore, acupuncture-responsive miRNAs may contribute
to the therapeutic effects of acupuncture in hypertension
through various pathways.
Our bioinformatic data also showed that there were 14
pathways regulated by the miRNAs responsive to acupuncture therapy (Table 3). Among these pathways, the neurotrophin signaling pathway plays critical roles in the regulation of brain activities and blood pressure control. Neurotrophins are a family of growth factors that induce the survival, development, and function of neurons [44, 45], which
also play an important role in pathogenesis of hypertension
[46] and in the neuroprotective activity of acupuncture
treatment. The cardiovascular system is tightly controlled
by the nervous system; neurons, cardiomyocytes, endothelial
cells, and vascular smooth muscle cells are all well regulated
by neurotrophins [46–49]. Our data suggest that acupuncture might regulate blood pressure through microRNAneurotrophin signaling pathway. Studies by us and others
have demonstrated that acupuncture activated neurotrophin
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Acupuncture at taichong point

Changes of brain miR-339, miR-223, and
miR-145

Neurotrophin signaling pathway

Regulating blood pressure

Figure 4: Proposed role of miRNAs in the antihypertensive effects
of acupuncture.

signaling pathway and elicited neuroprotective activity [50–
52]. Recent studies have showed that microRNA can not only
regulate neurotrophin expression, but also target their receptors and downstream signaling proteins [53, 54]. For example,
miR-206 was found to decrease brain-derived neurotrophic
factor level [53, 54] and miR-21 regulated neuron growth
factor signaling pathway in rats [55]. miR-592 was shown
to modulate the induction of p75 neurotrophin receptor in
neuronal ischemic injury [56]. Our data together with data
from other groups suggest that acupuncture could modulate
various miRNAs which consequently altered the function
and activities of critical neuronal and cardiovascular factors
contributing to the regulation of blood pressure (Figure 4).
The acupuncture-responsive miRNAs are supposed to play
important roles in the therapeutic effects of acupuncture
treatment for hypertension, but further mechanistic studies
are warranted to elicit how these responsive miRNAs contribute to the antihypertensive activity of acupuncture.
In addition, our bioinformatics data predicted that
mitogen-activated protein kinase (MAPK) signaling pathway
was possibly involved in the antihypertensive activity of
acupuncture in rats. The MAPK signaling molecules have
been recognized as important mediators in directing cellular
responses to a diverse array of stimuli, such as proinflammatory cytokines and exposure to environmental compounds.
They regulate gene expression, differentiation, apoptosis and
many other cellular processes [57]. Studies have showed that
MAPK signaling pathway was activated by acupuncture in the
brain [58]. Further functional studies are needed to dissect
the role of MAPK signalling pathway in the therapeutic
effects of acupuncture.
In summary, our microarray study for the first time
identified 222 differentially expressed miRNAs in the medulla
of SHRs treated with acupuncture at the taichong acupoint.
Among these miRNAs, 23 miRNAs were found to be differentially expressed in acupuncture-treated SHRs compared
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to untreated control rats. These 23 miRNAs could regulate
2963 target genes based on our bioinformatic analysis. Importantly, our RT-PCR assay has confirmed that miRNA-339,
miR-223, and miR-145 were upregulated in SHRs treated
with acupuncture at taichong acupoint in comparison with
the nonacupoint group. Our findings have demonstrated
significant changes of specific and selective miRNAs in rats
when taichong acupoint was stimulated. Our data have
revealed the specific miRNA profile changes in response to
acupuncture treatment and strongly suggest that a selective
panel of miRNAs play an important role in the antihypertensive activity of acupuncture therapy.
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